Novavax, Inc. (NVAX) - Earnings & Price History

NVAX: Novavax, Inc. - 1.12, $327.59M, 0.03 (2.75%)

Sector: Healthcare - Industry: Biotechnology

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage

Past NVAX reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-27AMC-0.231.511.631.51.451.58-7.98%0.67%-7.36%10.60M
2016-11-09AMC-0.261.41.71.471.321.53-13.53%▲-4.76%-17.65%22.82M
2016-08-09AMC-0.256.837.577.336.727.37-3.17%-6.82%-9.78%11.05M
2016-05-04AMC-0.274.584.784.714.514.82-1.46%-2.76%-4.18%6.28M
2016-02-29BMO-0.144.364.714.664.224.8-1.06%-6.44%-7.43%12.03M
2015-11-09-0.097.027.497.56.777.50.13%▲-6.40%-6.28%9.07M
2015-08-10AMC-0.0913.8911.1912.3312.3115.0110.19%12.65%24.13%30.84M
2015-05-07AMC-0.118.237.897.857.858.32-0.51%4.84%4.31%3.99M
2015-02-26AMC-0.089.159.318.658.519.25-7.09%5.78%-1.72%5.22M
2014-11-05AMCNovavax Inc-0.085.155.135.194.945.311.17%▲-0.77%0.39%3.36M
2014-08-06AMCNovavax Inc-0.06-0.084.224.584.334.14.38-5.46%-2.54%-7.86%3.69M
2014-05-07AMCNovavax Inc-0.073.824.013.93.84.15-2.74%-2.05%-4.74%3.38M
2014-03-10AMCNovavax Inc-0.08-0.075.95.866.275.856.597.00%-5.90%0.68%9.63M
2013-11-07BMONovavax Inc-0.06-0.092.762.812.822.682.870.36%▲-2.13%-1.78%2.04M
2013-08-08BMONovavax Inc-0.05-0.082.362.62.592.332.59-0.38%-8.88%-9.23%3.39M
2013-05-07BMO-0.062.062.252.32.032.352.22%-10.43%-8.44%2.06M
2013-03-01BMO-0.041.831.821.791.721.83-1.65%2.23%0.55%458.08K
2012-11-02BMO-0.041.942.032.031.932.06-4.43%-4.43%942.66K
2012-08-03BMOQ2 2012 Novavax Earn-0.052.092.112.072.052.17-1.90%0.97%-0.95%1.06M
2012-05-04BMOQ1 2012 Novavax Earn-0.04-0.061.381.351.351.321.392.22%2.22%1.01M
2012-03-09BMOQ4 2011 Novavax Inc -0.04-0.031.291.311.311.261.32-1.53%-1.53%385.20K
2011-11-04BMOQ3 2011 Novavax Inc -0.05-0.031.551.541.551.451.570.65%▲0.65%442.90K
2011-08-05BMOQ2 2011 Novavax Inc -0.07-0.031.461.571.621.451.653.18%-9.88%-7.01%1.32M
2011-05-09BMOQ1 2011 Novavax Inc -0.072.292.332.392.292.432.58%-4.18%-1.72%638.50K
2011-03-28BMOQ4 2010 Novavax Earn-0.09-0.062.532.512.592.522.653.19%-2.32%0.80%1.30M
2010-11-05BMOQ3 2010 Novavax Earn-0.09-0.12.332.432.342.322.37-3.70%▲-0.43%-4.12%777.20K
2010-08-06BMOQ2 2010 Novavax Earn-0.1-0.092.222.282.262.212.27-0.88%-1.77%-2.63%406.40K
2010-05-10BMOQ1 2010 Novavax Earn-0.12-0.112.722.352.692.512.7414.47%1.12%15.74%2.03M
2010-03-12BMOQ4 2009 Novavax Earn-0.06-0.152.332.482.492.322.530.40%-6.43%-6.05%1.88M
2009-11-06BMOQ3 2009 Novavax Earn-0.09-0.083.944.033.963.854.03-1.74%▲-0.51%-2.23%1.64M
2009-08-07Q2 2009 Novavax Earn-0.11-0.14.934.94.724.74.99-3.67%4.45%0.61%3.12M
2009-05-08BMOQ1 2009 Novavax Earn-0.121.771.781.791.581.80.56%-1.12%-0.56%2.55M
2009-03-31Q4 2008 Novavax Earn-0.13-0.110.941.021.040.91.041.96%-9.62%-7.84%212.00K
2008-11-10BMOQ3 2008 Novavax Earn-0.15-0.162.192.262.362.152.364.42%▲-7.20%-3.10%102.50K
2008-08-08BMOQ2 2008 Novavax Earn-0.142.572.372.482.432.684.64%3.63%8.44%390.50K
2008-05-09BMOQ1 2008 Novavax Earn-0.13-0.122.712.632.562.512.72-2.66%5.86%3.04%212.10K
2008-03-14BMOQ4 2007 Novavax Earn-0.14-0.152.732.762.752.522.88-0.36%-0.73%-1.09%402.00K
2007-11-12BMOQ3 2007 Novavax Earn-0.13-0.153.493.63.553.413.59-1.39%▲-1.69%-3.06%506.90K
2007-08-10BMOQ2 2007 Novavax Earn-0.133.183.12.92.823.22-6.45%9.66%2.58%858.50K
2007-05-11BMOQ1 2007 Novavax Earn-0.1-0.143.093.023.032.993.130.33%1.98%2.32%461.60K
2007-03-14BMOQ4 2006 Novavax Earn-0.09-0.12.832.932.842.773.05-3.07%-0.35%-3.41%1.67M
2006-11-14BMOQ3 2006 Novavax Earn-0.11-0.084.94.954.94.614.92-1.01%▲-1.01%2.09M
2006-08-14BMOQ2 2006 Novavax Earn-0.07-0.12.843.112.892.843.23-7.07%-1.73%-8.68%3.87M
2006-05-15BMOQ1 2006 Novavax Earn-0.14-0.115.254.965.235.15.385.44%0.38%5.85%3.50M
2006-03-01Q4 2005 Novavax Earn-0.080.135.385.695.655.345.66-0.70%-4.78%-5.45%6.10M
2005-11-08BMOQ3 2005 Novavax Earn-0.11-0.063.913.884.063.834.14.64%▲-3.69%0.77%6.36M
2005-08-09BMOQ2 2005 Novavax Earn-0.140.870.910.90.850.95-1.10%-3.33%-4.40%190.70K
2005-05-10BMOQ1 2005 Novavax Earn-0.14-0.221.591.391.21.131.62-13.67%32.50%14.39%422.70K
2005-03-14AMCQ4 2004 Novavax Earn1.642.091.721.352-17.70%-4.65%-21.53%1.47M
2004-11-03AMCQ3 2004 Novavax Earn3.753.873.853.543.85-0.52%▲-2.60%-3.10%388.90K
2004-08-09AMCQ2 2004 Novavax Earn3.783.723.763.583.921.08%0.53%1.61%491.70K
2004-05-05AMCQ1 2004 Novavax Earn4.755.15.24.525.21.96%-8.65%-6.86%397.70K
2004-03-10AMCQ4 2003 Novavax Earn5.895.65.65.386.255.18%5.18%373.80K
2003-11-10AMCQ3 2003 Novavax Earn6.296.276.356.056.51.28%▲-0.94%0.32%249.70K
2003-08-12AMCQ2 2003 Novavax Earn5.555.535.65.415.881.27%-0.89%0.36%117.80K
2003-05-13AMCQ1 2003 Novavax Earn4.034.094.2344.373.42%-4.73%-1.47%101.70K
2003-03-19BMOQ4 2002 Novavax Earn4.274.264.184.14.28-1.88%2.15%0.23%66.30K
2002-11-12BMOQ3 2002 Novavax Earn3.43.813.873.44.051.57%▲-12.14%-10.76%104.90K
2002-08-12BMOQ2 2002 Novavax Earn3.933.733.783.54.161.34%3.97%5.36%44.50K
2002-05-10Q1 2002 Novavax Earn4.64.524.644.54.752.65%-0.86%1.77%51.40K
2002-02-20AMCQ4 2001 Novavax Earn109.869.829.510.48-0.41%1.83%1.42%161.80K
1999-11-12BMONovavax Earnings Rel5.55.445.315.125.5-2.39%▲3.58%1.10%35.90K

Login | Register
Saturday Dec 15, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades